TREM1 and metabolic dysfunction-associated steatotic liver disease: Additionally, TREM-1 upregulation has been implicated in non-alcoholic fatty liver disease [10], hepatocellular carcinoma, neurodegenerative disorders [11], and neonatal sepsis.